featured
Progress in NSCLC Molecular Characterization for Personalized Medicine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Douillard JY, Ostoros G, Cobo M, et al. First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase IV, open label, single arm study. Br J Cancer. 2014;110(1):55-62.
- Diaz LA, Bardelli A. Liquid Biopsies: Genotyping Circulating Tumor DNA [published online ahead of print January 12, 2014]. J Clin Oncol. doi/10.1200/JCO.2012.45.2011.
- Oxnard GR, Paweletz CP, Kuang Y, et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA [published online ahead of print January 15, 2014. Clin Cancer Res. doi: 10.1158/1078-0432.CCR-13-2482.